LEXXW vs LW · rev $705.9K vs P/E 21, rev $6.61B
Lexaria Bioscience Corp (LEXXW) versus Lamb Weston Holdings Inc (LW) — a side-by-side from cached financials, not a winner call.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Lamb Weston Holdings Inc (LW) is a packaged foods company listed on US.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
Latest reported LW revenue for 2026-05-31 was $6.61B. Net income was $290.0M. Revenue was up 2.5% from 2025-05-25 to 2026-05-31. LW currently screens at market cap $7.40B and trailing P/E 20.6.
LEXXW currently screens at market cap $33.8M. LW currently screens at market cap $7.40B and trailing P/E 20.6.
Not investment advice. Open the LEXXW and LW stock pages for the full models.
Not investment advice.